The stock of Amryt Pharma PLC (LON:AMYT) hit a new 52-week low and has GBX 12.62 target or 11.00% below today’s GBX 14.18 share price. The 7 months bearish chart indicates high risk for the GBX 29.60 million company. The 1-year low was reported on Nov, 21 by Barchart.com. If the GBX 12.62 price target is reached, the company will be worth GBX 3.26M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock decreased 2.21% or GBX 0.32 on November 21, hitting GBX 14.18. Amryt Pharma PLC (LON:AMYT) has declined 28.40% since April 22, 2016 and is downtrending. It has underperformed by 32.26% the S&P500.
Amryt Pharma plc, formerly Fastnet Equity plc, is a United Kingdom specialty pharmaceutical company. The company has a market cap of 29.60 million GBP. The Firm focuses on developing and delivering treatments for patients with rare and orphan diseases. It currently has negative earnings. The Company’s products include Episalvan and Imlan.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.